Barely Significant
← all excerpts

PERsistent Sitagliptin treatment & Outcomes (PERS&O 2.0) study, long-term results: a real-world observation on DPP4-inhibitor effectiveness.

BMJ Open Diabetes Res Care · 2020 · PMC7478001 · PMID 32900698

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

a significant trendp<0.001actually significant
The UKPDS RE score at 10 years was evaluated over time during sitagliptin treatment ( figure 3 ): there was a significant trend of risk reduction over time (*p<0.001), with significant reductions from baseline at each time point of observation (p<0.05).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.